[
    {
        "molecule_name": "boronic acids",
        "protein_target_name": "thrombin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "100",
        "unit": "nM",
        "raw_mentions": "The boronic acids may have a Ki for thrombin of about 100 nM or less, e.g. about 20 nM or less."
    },
    {
        "molecule_name": "boronic acids",
        "protein_target_name": "thrombin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "20",
        "unit": "nM",
        "raw_mentions": "The boronic acids may have a Ki for thrombin of about 100 nM or less, e.g. about 20 nM or less."
    },
    {
        "molecule_name": "TRI 50b",
        "protein_target_name": "platelet procoagulant activity",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "IC50",
        "value": "308",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nTRI 50b proved to be a potent Inhibitor of platelet procoagulant activity with IC50's as summarised below:\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Thrombin3083000\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Collagen45200300\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Thrombin/Collagen110380\nTable 2 records, for example, that when platelets were treated with thrombin they caused a 30-fold acceleration of the rate of activation of prothrombin in comparison with control platelets, with an IC50 of 308 nM.\nThe significant potency of TRI 50 is evidenced by the fact that the IC50 values are in the nanomolar range."
    },
    {
        "molecule_name": "TRI 50b",
        "protein_target_name": "platelet procoagulant activity",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "IC50",
        "value": "452",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nTRI 50b proved to be a potent Inhibitor of platelet procoagulant activity with IC50's as summarised below:\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Thrombin3083000\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Collagen45200300\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Thrombin/Collagen110380\nTable 2 records, for example, that when platelets were treated with thrombin they caused a 30-fold acceleration of the rate of activation of prothrombin in comparison with control platelets, with an IC50 of 308 nM.\nThe significant potency of TRI 50 is evidenced by the fact that the IC50 values are in the nanomolar range."
    },
    {
        "molecule_name": "TRI 50b",
        "protein_target_name": "platelet procoagulant activity",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "IC50",
        "value": "110",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nTRI 50b proved to be a potent Inhibitor of platelet procoagulant activity with IC50's as summarised below:\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Thrombin3083000\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Collagen45200300\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Thrombin/Collagen110380\nTable 2 records, for example, that when platelets were treated with thrombin they caused a 30-fold acceleration of the rate of activation of prothrombin in comparison with control platelets, with an IC50 of 308 nM.\nThe significant potency of TRI 50 is evidenced by the fact that the IC50 values are in the nanomolar range."
    },
    {
        "molecule_name": "TRI 50b",
        "protein_target_name": "prothrombin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "IC50",
        "value": "308",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nTRI 50b proved to be a potent Inhibitor of platelet procoagulant activity with IC50's as summarised below:\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Thrombin3083000\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Collagen45200300\nIC50 plus pre-IC50 withoutFold accelerationincubationincubationAgonistwithout TRI 50b(nM)(nM)Thrombin/Collagen110380\nTable 2 records, for example, that when platelets were treated with thrombin they caused a 30-fold acceleration of the rate of activation of prothrombin in comparison with control platelets, with an IC50 of 308 nM.\nThe significant potency of TRI 50 is evidenced by the fact that the IC50 values are in the nanomolar range."
    },
    {
        "molecule_name": "boronic acid",
        "protein_target_name": "thrombin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "<=100",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n7. A formulation of any of paragraphs 1 to 6 wherein the boronic acid has a Ki for thrombin of about 100 nM or less.\n8. A formulation of paragraph 7 wherein the boronic acid has a Ki for thrombin of about 20 nM or less."
    },
    {
        "molecule_name": "boronic acid",
        "protein_target_name": "thrombin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "<=20",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n7. A formulation of any of paragraphs 1 to 6 wherein the boronic acid has a Ki for thrombin of about 100 nM or less.\n8. A formulation of paragraph 7 wherein the boronic acid has a Ki for thrombin of about 20 nM or less."
    },
    {
        "molecule_name": "boronic acid",
        "protein_target_name": "thrombin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "100",
        "unit": "nM",
        "raw_mentions": "120. A medicament of paragraph 119 wherein the boronic acid has a Ki for thrombin of about 100 nM or less.\n121. A medicament of paragraph 119 wherein the boronic acid has a Ki for thrombin of about 20 nM or less."
    },
    {
        "molecule_name": "boronic acid",
        "protein_target_name": "thrombin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "20",
        "unit": "nM",
        "raw_mentions": "120. A medicament of paragraph 119 wherein the boronic acid has a Ki for thrombin of about 100 nM or less.\n121. A medicament of paragraph 119 wherein the boronic acid has a Ki for thrombin of about 20 nM or less."
    }
]